huprine x has been researched along with propidium in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Al-Rashid, ZF; Beri, V; Cheung, J; Rosenberry, TL; Shiomi, K; Wildman, SA | 1 |
| Camps, P; Cusack, B; El Achab, RE; Mallender, WD; Morral, J; Muñoz-Torrero, D; Rosenberry, TL | 1 |
| Badia, A; Camps, P; Clos, MV; Colombo, L; Manzoni, C; Muñoz-Torrero, D; Pera, M; Ratia, M; Román, S; Salmona, M | 1 |
3 other study(ies) available for huprine x and propidium
| Article | Year |
|---|---|
The natural product dihydrotanshinone I provides a prototype for uncharged inhibitors that bind specifically to the acetylcholinesterase peripheral site with nanomolar affinity.
Topics: Acetylcholine; Acetylcholinesterase; Aflatoxin B1; Binding Sites; Binding, Competitive; Catalysis; Catalytic Domain; Cholinesterase Inhibitors; Crystallography, X-Ray; Furans; Humans; Hydrolysis; Kinetics; Models, Chemical; Phenanthrenes; Pyrans; Quinones; Recombinant Proteins; Structure-Activity Relationship; Substrate Specificity | 2013 |
Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease.
Topics: Acetylcholinesterase; Acylation; Alzheimer Disease; Aminoquinolines; Binding, Competitive; Cholinesterase Inhibitors; Erythrocytes; Heterocyclic Compounds, 4 or More Rings; Humans; Intercalating Agents; Kinetics; Propidium | 2000 |
Acetylcholinesterase triggers the aggregation of PrP 106-126.
Topics: Acetylcholinesterase; Alkaloids; Aminoquinolines; Animals; Cattle; Cholinesterase Inhibitors; Coumarins; Heterocyclic Compounds, 4 or More Rings; Humans; Microscopy, Fluorescence; Peptide Fragments; Prions; Propidium; Protein Structure, Secondary; Sesquiterpenes | 2006 |